🇺🇸 FDA
Patent

US 6210873

Methods and compositions for the priming of specific cytotoxic T-lymphocyte response

expired A61KA61K39/00A61K40/11

Quick answer

US patent 6210873 (Methods and compositions for the priming of specific cytotoxic T-lymphocyte response) held by The Board of Regents of the University of Texas System expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K39/00, A61K40/11, A61K40/46